Company Profile

Athira Pharma Stock Price, News & Analysis

Ticker:
ATHA
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
United States

Stock performance

6.75 USD

Close

Last updated: January 9, 2026 at 00:00

Market cap

Why the stock is moving

ATHA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Athira Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Athira Pharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.

Business Model Characteristics

Athira Pharma follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.

Position Within the Biotechnology Landscape

Compared with more mature healthcare names, Athira Pharma sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.

Future catalysts

Recent news

The five most recent related feed items are shown below in reverse chronological order.

  1. 01

    Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

    ZBH · Source: Zimmer Biomet

  2. 02
  3. 03
  4. 04
  5. 05

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of Athira Pharma (ATHA)?

Athira Pharma (ATHA) most recently closed at 6.75 USD.

What does Athira Pharma do?

Athira Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

On which exchange is ATHA stock listed?

Athira Pharma (ATHA) is associated with NASDAQ, United States, Biotechnology.

What is Athira?

Athira Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Which conditions is Athira Pharma targeting with Athira?

Athira Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

What is Pharma?

Athira Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.